Oxygen‐carrying semiconducting polymer nanoprodrugs induce sono‐pyroptosis for deep‐tissue tumor treatment
Top Cited Papers
Open Access
- 19 February 2024
- journal article
- research article
- Published by Wiley in Exploration
- Vol. 4 (4) , 20230100
Abstract
Sonodynamic therapy (SDT) has been explored for cancer therapy, especially for deep tumors due to its low tissue penetration restriction. The therapeutic efficacy of SDT is limited due to the complicated tumor microenvironment. This study reports the construction of oxygen‐carrying semiconducting polymer nanoprodrugs (OSPNpro) for deep tumor treatment via combining amplified SDT with pyroptosis. An oxygen carrier perfluorohexane, sonodynamic semiconducting polymer as the sonosensitizer, and reactive oxygen species (ROS)‐responsive prodrug are co‐loaded into a nanoparticle system, leading to the formation of these polymer nanoprodrugs. Such OSPNpro show an effective accumulation in tumor tissues after systemic administration, in which they deliver oxygen to relieve tumor hypoxia microenvironment and thus mediate amplified SDT via producing ROS under ultrasound (US) irradiation, even when the tumors are covered with a 2‐cm chicken breast tissue. In addition, the ROS‐responsive prodrugs are activated by the generated ROS to trigger pyroptosis of tumor cells. Such a sono‐pyroptosis induces a strong antitumor immunity with obviously higher level infiltrations of effector immune cells into tumors. Therefore, OSPNpro‐based combinational therapy can greatly inhibit the growth of 2‐cm chicken breast tissue‐covered deep tumors and suppress tumor metastasis. This study offers a prodrug nanoplatform for treatment of deep tumor via sono‐pyroptosis strategy.Keywords
Funding Information
- National Natural Science Foundation of China (52203155)
- Science and Technology Commission of Shanghai Municipality (23WZ2504600, 22490760700, 22ZR1401100)
- Fundamental Research Funds for the Central Universities (2232021A‐05)
This publication has 59 references indexed in Scilit:
- A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic ImmunotherapyAdvanced Functional Materials, 2023
- Diselenide‐Based Dual‐Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer ImmunotherapyAdvanced Healthcare Materials, 2022
- Immunomodulatory‐Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor ImmunotherapyAdvanced Healthcare Materials, 2022
- Open‐Shell Nanosensitizers for Glutathione Responsive Cancer Sonodynamic TherapyAdvanced Materials, 2022
- Nanoengineered Neutrophils as a Cellular Sonosensitizer for Visual Sonodynamic Therapy of Malignant TumorsAdvanced Materials, 2022
- Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of GlioblastomaAdvanced Materials, 2022
- 2D Piezoelectric Bi2MoO6 Nanoribbons for GSH‐Enhanced Sonodynamic TherapyAdvanced Materials, 2021
- Inspired Epigenetic Modulation Synergy with Adenosine Inhibition Elicits Pyroptosis and Potentiates Cancer ImmunotherapyAdvanced Functional Materials, 2021
- Implantable Bioresponsive Nanoarray Enhances Postsurgical Immunotherapy by Activating Pyroptosis and Remodeling Tumor MicroenvironmentAdvanced Functional Materials, 2020
- Micro/Nanoparticle‐Augmented Sonodynamic Therapy (SDT): Breaking the Depth Shallow of PhotoactivationAdvanced Materials, 2016